Members Sought for Director's Consumer Liaison Group: NCI

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 7
Volume 6
Issue 7

BETHESDA, Md--The NCI is calling for nominations for a new initiative--the Director's Consumer Liaison Group (DCLG). This group will help the NCI increase the representation of the cancer advocacy community on NCI advisory committees and increase the involvement of consumer advocates in program and policy development.

BETHESDA, Md--The NCI is calling for nominations for a new initiative--theDirector's Consumer Liaison Group (DCLG). This group will help the NCIincrease the representation of the cancer advocacy community on NCI advisorycommittees and increase the involvement of consumer advocates in programand policy development.

It will consist of 15 consumer advocates brought together from manyadvocacy communities. To be eligible for the DCLG, a nominee must be involvedin the cancer experience as a cancer survivor, a person affected by thesuffering and consequences of cancer, or a professional/volunteer who workswith survivors or those affected.

Nominations can be made by organizations, including local/regional andnational groups, or by individuals, including self-nominations.

For more information and to receive a nomination package, send yourname, advocacy organization affiliation (if any), and address to the Officeof Liaison Activities, NCI, c/o Palladian Partners, 7315 Wisconsin Avenue,Suite 440W, Bethesda, MD 20814. Fax: 301-986-5047. Nominations must bepostmarked by September 15, 1997.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content